Pulmonary nitric oxide synthases and nitrotyrosine: Findings during lung development and in chronic lung disease of prematurity

Pediatrics

Volumn 118, Issue 3, 2006, Pages 1056-1064

  Sheffield, Mark ^a   Mabry, Sherry ^a   Thibeault, Donald W ^a   Truog, William E ^a,b  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Lung development; Nitrotyrosine; Pulmonary nitric oxide synthases

Indexed keywords

3 NITROTYROSINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; 3-NITROTYROSINE; DRUG DERIVATIVE; NITRIC OXIDE SYNTHASE; NOS1 PROTEIN, HUMAN; NOS2A PROTEIN, HUMAN; NOS3 PROTEIN, HUMAN; TYROSINE;

ARTICLE; BRONCHUS; CHRONIC LUNG DISEASE; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME METABOLISM; GESTATIONAL AGE; HUMAN; IMMUNOCHEMISTRY; LUNG ALVEOLUS; LUNG DEVELOPMENT; ONTOGENY; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; AGE; AUTOPSY; CHRONIC DISEASE; COMPARATIVE STUDY; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; HOSPITALIZATION; IMMUNOHISTOCHEMISTRY; LUNG; LUNG DISEASE; METABOLISM; NEWBORN;

AGE FACTORS; AUTOPSY; CHRONIC DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; INFANT, PREMATURE; LUNG; LUNG DISEASES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; SEVERITY OF ILLNESS INDEX; TYROSINE;

EID: 33749076070     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-0195     Document Type: Article

References (40)

1. Roberts Jr JD, Fineman JR, Morin III FC, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med. 1997;336:605-610
2. Group NINO. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med. 1997;336:597-604
3. Wessel D, Adatia I, Van Marter L, et al. Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics. 1997;100(5). Available at: www.pediatrics.org/cgi/content/full/100/5/e7
4. Mahut B, Delacourt C, Zerah-Lancner F, De Blic J, Harf A. Increase in alveolar nitric oxide in the presence of symptoms in childhood asthma. Chest. 2004;125:1012-1018
5. Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med. 2003;349:2099-2107
6. Field D, Elbourne D, Truesdale A, et al for the INNOVO Trial Collaborating Group. Neonatal ventilation with inhaled nitric oxide versus ventilatory support without inhaled nitric oxide for preterm infants with severe respiratory failure: the INNOVO multicentre randomized controlled trial. Pediatrics. 2005;115:926-936
7. Van Meurs KP, Wright LL, Ehrenkranz RA, et al for the Premie Inhaled Nitric Oxide Study. Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med. 2005;353:13-22
8. Huie R, Padmaja S. The reaction of NO with superoxide. Free Radic Res Commun. 1993;18:195-199
9. Stamler JS, Singel DJ, Loscalso J. Biochemistry of nitric oxide and its redox-activated forms. Science. 1992;258:1898-1902
10. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res. 1999;46:641-643
11. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:494-498
12. Truog WE. Chronic lung disease and randomized interventional trials: status in 2005. Neo Reviews. 2005;6:e278
13. American Academy of Pediatrics. Committee on Fetus and Newborn and Canadian Paediatric Society, Fetus and Newborn Committee. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics. 2002;109:330-338
14. Thibeault DW, Truog WE, Ekekezie II. Acinar arterial changes with chronic lung disease of prematurity in the surfactant era. Pediatr Pulm. 2003;36:482-489
15. Thibeault DW, Mabry SM, Ekekezie II, Zhang X, Truog WE. Collagen scaffolding during development and its deformation with chronic lung disease. Pediatrics. 2003;111:766-776
16. Thibeault DW, Mabry SM, Norberg M, Truog WE, Ekekezie II. Lung microvascular adaptation in infants with chronic lung disease. Biol Neonate. 2004;85:273-282
17. Thibeault DW, Mabry SM, Ekekezie II, Truog WE. Lung elastic tissue maturation and perturbations during the evolution of chronic lung disease. Pediatrics. 2000;106:1452-1459
18. Hsu SM, RaineL, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol. 1081;75:816-821
19. Abman S, Chatfield B, Hall S, McMurtry I. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol. 1990;259:H1921-H1927
20. Abman S, Groothius J. Pathophysiology and treatment of bronchopulmonary dysplasia. Pediatr Clin North Am. 1994;159:277-315
21. Black S, Johengen M, Ma Z, Bristow J, Soifer S. Ventilation and oxygenation induce endothelial nitric oxide synthase gene expression in the lungs of fetal lambs. J Clin Invest. 1997;100:1448-1458
22. MacRitchie AN, Albertine KH, Sun J, et al. Reduced endothelial nitric oxide synthase in lungs of chronically ventilated preterm lambs. Am J Physiol. 2001;281:L1011-L1020
23. Sherman TS, Zhong C, Yuhanna IS, Lau KS, Margraf LR, Shaul PW. Nitric oxide synthase isoform expression in the developing lung epithelium. Am J Physiol. 1999;276:L383-L390
24. Xue C, Botkin S, Johns R. Localization of endothelial NOS at the basal microtubule membrane in ciliated epithelium of rat lung. J Histochem Cytochem. 1996;44:463-471
25. Xue C, Reynolds P, Johns R. Developmental expression of NOS isoforms in fetal rat lung: implications for transitional circulation and pulmonary angiogenesis. Am J Physiol. 1996;270:L88-L100
26. Bland RD, Albertine KH, Carlton DP, MacRitchie AJ. Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med. 2005;172:899-906
27. Afshar S, Gibson LL, Yuhanna IS, et al. Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease. Am J Physiol Lung Cell Mol Physiol. 2003;284:L749-L758
28. Aikio O, Vuopala K, Pokela ML, Andersson S, Hallman M. Nitortyrosine and NO synthases in infants with respiratory failure: influence of inhaled NO. Pediatr Pulmonol. 2003;35:8-16
29. Kobzik L, Bredt D, Lowenstein C, et al. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol. 1993;9:371-377
30. Watkins DN, Peroni DJ, Basclain KA, Garlepp MJ, Thompson PJ. Expression and activity of nitric oxide synthase in human airway epithelium. Am J Respir Cell Mol Biol. 1997;16:629-639
31. Beckman JS, Ischiropoulos H, Zhu L, et al. Kinetics of superoxide dismutase - and iron-catalyzed nitration of phenolics by peroxynitrite. Arch Biochem Biophy. 1992;298:438-445
32. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol. 1996;271:C1424-C1437
33. Ischiropoulos H, Zhu L, Chen J, et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch of Biochem Biophy. 1992;298:431-437
34. Choi H-S, Rai PR, Chu HW, Cool C, Chan ED. Analysis of nitric oxide synthase and nitrotyrosine expression in human pulmonary tuberculosis. Am J Respir Crit Care Med. 2002;166:178-186
35. Sittipunt C, Ruzinski JT, Myles C, et al. Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;163:503-510
36. Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med. 1995;151:1250-1254
37. Haddad IY, Pataki G, Hu P, Galliani C, Beckman JS, Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest. 1994;94:2407-2413
38. Banks BA, Ischiropoulos H, McClelland M, Ballard PL, Ballard RA. Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia. Pediatrics. 1998;101:870-874
39. Lorch SA, Banks BA, Christie J, et al. Plasma 3-nitrotyrosine and outcome in neonates with severe bronchopulmonary dysplasia after inhaled nitric oxide. Free Radic Biol Med. 2003;34:1146-1152
40. Olsen SL, Clark PL, Thibeault DW, Norberg M, Truog WE. Exhaled nitric oxide and tracheal endothelin-1 in preterm infants with and without RDS. Pediatr Pulm. 2003;36:421-426